The Combination of Bcl-2 Inhibitor Venetoclax and Mcl-1 Inhibitor MIK665 induces Cell Death in HCC Cells

被引：0
|
作者：
Walz, Franziska [1 ]
Michalski, Marlen [1 ]
Aschenbrenner, Elisabeth [1 ]
Mueller-Schilling, Martina [1 ]
Guelow, Karsten [1 ]
机构：
[1] Univ Klinikum Regensburg, Klin & Poliklin Innere Med 1, Regensburg, Germany
来源：
INTERNIST | 2022年 / 63卷 / SUPPL 3期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PS041
引用
收藏
页码：328 / 329
页数：2
相关论文
共 50 条
  • [41] Synergistic Action of MCL-1 Inhibitor with BCL-2/BCL-XL or MAPK Pathway Inhibitors Enhances Acute Myeloid Leukemia Cell Apoptosis and Differentiation
    Opydo, Malgorzata
    Mlyczynska, Anna
    Mlyczynska, Ewa
    Rak, Agnieszka
    Kolaczkowska, Elzbieta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [42] A combination of BR101801 and venetoclax enhances antitumor effect in DLBCL cells via c-Myc/Bcl-2/Mcl-1 triple targeting
    Jeon, Byeongwook
    Lee, Yun Ji
    Shin, Jisoo
    Choi, Min-Ji
    Lee, Chae-Eun
    Son, Mi Kwon
    Park, Jung Hee
    Kim, Bong-Seog
    Kim, Hong Ro
    Jung, Kyung Hee
    Cha, Jong-Ho
    Hong, Soon-Sun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (02): : 452 - +
  • [43] Effects of the Mcl-1/Bcl-2 Inhibitor GX015-070 (Obatoclax®) on Growth and Viability of Canine and Human Neoplastic Mast Cells
    Peter, Barbara
    Aichberger, Karl J.
    Gleixner, Karoline V.
    Ferenc, Veronika
    Gruze, Alexander
    Pickl, Winfried F.
    Willmann, Michael
    Valent, Peter
    BLOOD, 2008, 112 (11) : 318 - 319
  • [44] Preclinical Studies of Apogossypolone, a Novel Pan Inhibitor of Bcl-2 and Mcl-1, Synergistically Potentiates Cytotoxic Effect of Gemcitabine in Pancreatic Cancer Cells
    Banerjee, Sanjeev
    Choi, Minsig
    Aboukameel, Amro
    Wang, Zhiwei
    Mohammad, Mussop
    Chen, Jianyong
    Yang, Dajun
    Sarkar, Fazlul H.
    Mohammad, Ramzi M.
    PANCREAS, 2010, 39 (03) : 323 - 331
  • [45] The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines
    Klenke, Stefanie
    Akdeli, Neval
    Stelmach, Patrick
    Heukamp, Lukas
    Schulte, Johannes H.
    Bachmann, Hagen S.
    BMC CANCER, 2019, 19 (1)
  • [46] The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines
    Stefanie Klenke
    Neval Akdeli
    Patrick Stelmach
    Lukas Heukamp
    Johannes H. Schulte
    Hagen S. Bachmann
    BMC Cancer, 19
  • [47] The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines
    Bachmann, H. S.
    Akdeli, N.
    Heukamp, L.
    Schulte, J.
    Siffert, W.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 7 - 7
  • [48] Mcl-1 and FBW7 Control a Dominant Survival Pathway Underlying HDAC and Bcl-2 Inhibitor Synergy in Squamous Cell Carcinoma
    He, Lei
    Torres-Lockhart, Kristine
    Forster, Nicole
    Ramakrishnan, Saranya
    Greninger, Patricia
    Garnett, Mathew J.
    McDermott, Ultan
    Rothenberg, Stephen M.
    Benes, Cyril H.
    Ellisen, Leif W.
    CANCER DISCOVERY, 2013, 3 (03) : 324 - 337
  • [49] Bortezomib and Flavopiridol combination induces down regulation of Mcl-1, mitochondrial permeabilization and cell death in ALCL cells
    Zorzi, E.
    Bonvini, R.
    Mussolin, L.
    Basso, G.
    Rosolen, A.
    EJC SUPPLEMENTS, 2008, 6 (12): : 73 - 73
  • [50] Antimyeloma Effect of the Simultaneous Inhibition of MCL-1 (with S63845) and BCL-2 (with Venetoclax) in the Presence of the Microenvironment
    Algarin, Esperanza M.
    Diaz-Tejedor, Andrea
    Mogollon, Pedro
    Hernandez-Garcia, Susana
    Corchete, Luis
    San-Segundo, Laura
    Martin-Sanchez, Montserrat
    Gonzalez-Mendez, Lorena
    Schoumacher, Marie
    Banquet, Sebastien
    Kraus-Berthier, Laurence
    Kloos, Ioana
    Halilovic, Ensar
    Maacke, Heiko
    Gutierrez, Norma C.
    Mateos, Maria-Victoria
    Paino, Teresa
    Garayoa, Mercedes
    Ocio, Enrique M.
    BLOOD, 2018, 132
12345